INSULIN - ANVISA Registration 82444370226
Access comprehensive regulatory information for INSULIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82444370226 and manufactured by MACCURA BIOTECHNOLOGY CO LTD. The registration is held by Enzytec Biotecnologia Ltda. with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
82444370226
25351031251202543
07214566000165
Company Information
Dates and Status
Apr 28, 2025
VIGENTE
09/18/2025 19:00:01
INSULIN
Insulin Reagent Kit
LABTEST DIAGNOSTICA S/A
10009010434
Feb 14, 2024
INSULIN
INSULIN IMMULITE
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD.
10345160943
Oct 06, 2008
INSULIN
ELECSYS INSULINA
ROCHE DIAGNOSTICS GMBH
10287410454
May 23, 2005
INSULIN
INSULINA ELISA
LDN LABOR DIAGNOSTIKA NORD GMBH & CO.
80464810297
Sep 02, 2013
INSULIN
INSULINA ELISA
LDN
80836930023
May 26, 2014
INSULINA
Família Insulina (CLIA) e calibradores de insulina
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD
80943610272
Jul 07, 2025
INSULINA
Família AFIAS Insulin
BODITECH MED INC.
10350840457
May 13, 2024
INSULINA
ichroma™ Insulin
BODITECH MED INC.
10350840455
Apr 22, 2024
INSULINA
Insulin Reagent Kit
LABTEST DIAGNOSTICA S/A
10009010434
Feb 14, 2024
INSULINA
KIT DE DETECÇÃO PARA INSULINA - DIRUI
DIRUI INDUSTRIAL CO. LTD
82378830017
Jan 02, 2024